Hancock Whitney Corp Supernus Pharmaceuticals, Inc. Transaction History

Hancock Whitney Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 16, 2024	BUY	$27.11 - $35.17 $159,542 - $206,975	5,885 New	5,885 $200,000
Q1 2023 Nov 13, 2023	SELL	$34.93 - $42.03 $9,186 - $11,053	-263 Reduced 4.37%	5,758 $208,000
Q1 2023 May 16, 2023	SELL	$34.93 - $42.03 $9,186 - $11,053	-263 Reduced 4.37%	5,758 $209,000
Q4 2022 Nov 13, 2023	BUY	$31.09 - $37.88 $187,192 - $228,075	6,021 New	6,021 $214,000
Q4 2022 Feb 03, 2023	SELL	$31.09 - $37.88 $746 - $909	-24 Reduced 0.4%	6,021 $214,000
Q3 2022 Oct 26, 2022	BUY	$28.79 - $35.41 $174,035 - $214,053	6,045 New	6,045 $204,000
Q2 2022 Aug 08, 2022	SELL	$25.33 - $34.25 $158,109 - $213,788	-6,242 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$28.51 - $32.9 $177,959 - $205,361	6,242 New	6,242 $201,000
Q4 2019 Feb 06, 2020	SELL	$19.93 - $29.13 $235,472 - $344,170	-11,815 Closed	0 $0
Q3 2019 Oct 29, 2019	SELL	$25.47 - $33.37 $29,952 - $39,243	-1,176 Reduced 9.05%	11,815 $325,000
Q2 2019 Aug 29, 2019	BUY	$29.96 - $38.87 $6,351 - $8,240	212 Added 1.66%	12,991 $430,000
Q1 2019 May 13, 2019	SELL	$32.77 - $41.99 $241,351 - $309,256	-7,365 Reduced 36.56%	12,779 $448,000
Q4 2018 Feb 15, 2019	SELL	$30.84 - $49.51 $90,731 - $145,658	-2,942 Reduced 12.74%	20,144 $669,000
Q3 2018 Nov 14, 2018	BUY	$42.7 - $56.55 $624,060 - $826,478	14,615 Added 172.53%	23,086 $1.16 Million
Q2 2018 Aug 14, 2018	BUY	$44.1 - $59.85 $373,571 - $506,989	8,471 New	8,471 $507,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.